[unable to retrieve full-text content]
investors like invoice Ackman (Trades, Portfolio), Ruane Cunniff (Trades, Portfolio) and John Paulson (Trades, Portfolio) took hits to their portfolio as of late after an organization published a damning reporting on one among their key holdings, Valeant Pharmaceutical (VRX). the corporate’s shares plunged as a lot as 33% on Wednesday, after offering the traders strong paper positive aspects this yr.
http://chart.gurufocus.com/323085210.png
Forbes – non-public Finance
Facebook
Twitter
Instagram
Google+
LinkedIn
RSS